Protagonist Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 10.31 M | $1.26 B | 5.40% | 15.63% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2026 | 6.35 M | $778.25 M | 0.00% | 9.63% |
| RTW INVESTMENTS, LP | 08/14/2026 | 5.06 M | $620.40 M | 0.04% | 7.68% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 3.63 M | $444.88 M | 4.25% | 5.50% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 3.42 M | $418.83 M | -5.08% | 5.18% |
| UBS GROUP AG | 08/13/2026 | 3.40 M | $416.68 M | -34.35% | 5.16% |
| STATE STREET CORP | 09/22/2026 | 3.32 M | $407.16 M | 6.57% | 5.10% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.85 M | $349.77 M | 1.69% | 4.33% |
| JOHNSON & JOHNSON | 08/06/2026 | 2.45 M | $300.22 M | 0.00% | 3.71% |
| INVESCO LTD. | 08/14/2026 | 2.34 M | $286.92 M | 8.13% | 3.55% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 2.15 M | $263.51 M | 29.07% | 3.26% |
| JUPITER TOPCO LLC | 08/14/2026 | 2.13 M | $261.04 M | 100.00% | 3.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.74 M | $213.48 M | 4.30% | 2.64% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.41 M | $173.35 M | 0.00% | 2.14% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.32 M | $162.36 M | 2.24% | 2.01% |
| JENNISON ASSOCIATES LLC | 08/03/2026 | 1.15 M | $141.17 M | 7.43% | 1.75% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 981.88 K | $120.36 M | -20.23% | 1.49% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 960.86 K | $117.78 M | -3.35% | 1.46% |
| MORGAN STANLEY | 08/13/2026 | 905.99 K | $111.06 M | -11.02% | 1.37% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 889.30 K | $109.01 M | 49.92% | 1.35% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2026 | 882.74 K | $108.21 M | 6.45% | 1.34% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 812.85 K | $99.64 M | 4.35% | 1.23% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2026 | 731.05 K | $89.61 M | 1.40% | 1.11% |
| CLEARBRIDGE INVESTMENTS, LLC | 08/13/2026 | 725.34 K | $88.91 M | 16.65% | 1.10% |
| FMR LLC | 08/13/2026 | 672.19 K | $82.40 M | 1.54% | 1.02% |
| NORTHERN TRUST CORP | 08/13/2026 | 666.11 K | $81.65 M | 13.29% | 1.01% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 598.60 K | $73.38 M | 11.40% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 583.77 K | $71.56 M | 5.57% | 0.89% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 583.77 K | $71.56 M | 100.00% | 0.89% |
| VOYA INVESTMENT MANAGEMENT LLC | 08/12/2026 | 571.62 K | $70.07 M | 25.80% | 0.87% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 567.99 K | $69.62 M | -2.25% | 0.86% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 520.03 K | $63.75 M | 277.19% | 0.79% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 437.75 K | $53.66 M | 6.06% | 0.66% |
| LORD, ABBETT & CO. LLC | 08/14/2026 | 398.99 K | $48.91 M | 144.09% | 0.61% |
| PRINCIPAL FINANCIAL GROUP INC | 08/04/2026 | 385.26 K | $47.23 M | 4.74% | 0.58% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 358.30 K | $43.92 M | 4.93% | 0.54% |
| NEUBERGER BERMAN GROUP LLC | 08/13/2026 | 302.43 K | $37.07 M | 113.82% | 0.46% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 301.47 K | $36.95 M | 54.97% | 0.46% |
| 683 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 290.00 K | $35.55 M | -18.31% | 0.44% |
| NUVEEN, LLC | 08/11/2026 | 284.09 K | $34.82 M | 122.09% | 0.43% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 07/29/2026 | 281.83 K | $34.55 M | 100.00% | 0.43% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 259.97 K | $31.87 M | -15.05% | 0.39% |
| EAGLE HEALTH INVESTMENTS LP | 08/10/2026 | 248.32 K | $30.44 M | 38.48% | 0.38% |
| NEXTBIO CAPITAL MANAGEMENT LP | 08/14/2026 | 219.33 K | $26.89 M | -4.48% | 0.33% |
| SEGALL BRYANT & HAMILL, LLC | 08/12/2026 | 214.72 K | $26.32 M | 0.94% | 0.33% |
| SEB ASSET MANAGEMENT AB | 08/04/2026 | 209.96 K | $25.74 M | -9.66% | 0.32% |
| DUQUESNE FAMILY OFFICE LLC | 08/14/2026 | 208.90 K | $25.61 M | 30.81% | 0.32% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 08/13/2026 | 207.69 K | $25.46 M | -1.23% | 0.32% |
| CITIGROUP INC | 08/03/2026 | 198.67 K | $24.35 M | 25.18% | 0.30% |
| JPMORGAN CHASE & CO | 08/12/2026 | 183.10 K | $22.57 M | 5.84% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protagonist Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 432 institutional investors and hedge funds held shares of Protagonist Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 10.31 M
FARALLON CAPITAL MANAGEMENT LLC: 6.35 M
RTW INVESTMENTS, LP: 5.06 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 3.63 M
WELLINGTON MANAGEMENT GROUP LLP: 3.42 M
UBS Group AG: 3.4 M
115.84% of Protagonist Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 96.39 M shares in the last 24 months. This purchase volume represents approximately $9.32 B in transactions.